Dosing & Administration
This unit explains, for education only, the Russian-registered dosing and the community intranasal practices you will…
What the label says, and what it cannot tell you
This unit explains, for education only, the Russian-registered dosing and the community intranasal practices you will read about, so you can interpret them critically. It is not a protocol, a dose, or a recommendation, and no FDA-approved label for Selank exists in the United States.
The honest throughline is intranasal variability: the label itself warns that absorption can fall when nasal secretions are increased, and no source here says how much of a dose reaches the brain, so "precise" nasal dosing is something of an illusion.
Key terms
The Russian-registered protocol
The clearest reference point is the Russian-registered regimen, presented here as regulatory information, not a prescription. Note first what the registration document actually contains: a strength and a schedule, not a microgram dose. The label fixes the peptide content of the 0.15% solution per milliliter, alongside one preservative, methylparaben, and the instruction is 2 drops in each nostril three times daily for 14 days, repeatable after 1 to 3 weeks and only after consulting a doctor. Any microgram figure you see for Selank is arithmetic laid on top of that, resting on an assumed drop volume the label never states, which is why this course quotes none. The anxiety protocol is a defined short course rather than open-ended daily use.
Two features deserve emphasis. First, the regimen is a course: 14 days, then reassessment, not a permanent daily habit. Second, these are figures for one registered Russian product with a manufacturer behind it; they say nothing about the content of any unapproved vial elsewhere. The schedule is a reference, not an instruction.
This unit is education only and not medical advice. The Russian regimen is regulatory reference information, not a recommendation to use Selank.